Schizoaffective Disorders Completed Phase 4 Trials for Metformin (DB00331)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00391261An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.Treatment